- Correction
- Open access
- Published:
Correction: Exploring the effect of Yinzhihuang granules on alcoholic liver disease based on pharmacodynamics, network pharmacology and molecular docking
Chinese Medicine volume 18, Article number: 83 (2023)
The Original Article was published on 11 May 2023
Correction: Chinese Medicine (2023) 18:52Â https://doi.org/10.1186/s13020-023-00759-z
Following publication of the original article [1], the authors reported an error in the Experimental animal model and drug interventions section.
The original content is as follows:
After 1 week of adaptive feeding, mice were randomly divided into 6 groups (n = 6), namely control group (C), model group (M), 3.5 mg/kg of positive group (P), 3.69 g/kg of YZHG low dose group (YL), 7.38 g/kg of YZHG medium dose group (YM) and 14.76 g/kg of YZHG high dose group (YH). The doses of the positive drug (silibinin capsule) and YZHG were converted into corresponding doses based on the body surface area of humans and animals.
The revised content is as follows:
After 1 week of adaptive feeding, mice were randomly divided into 6 groups (n = 6), namely control group (C), model group (M), 43.05 mg/kg of positive group (P), 3.69 g/kg of YZHG low dose group (YL), 7.38 g/kg of YZHG medium dose group (YM) and 14.76 g/kg of YZHG high dose group (YH). The doses of the positive drug (silibinin capsule) and YZHG were converted into corresponding doses based on the body surface area of humans and animals.
The original article [1] has been corrected.
Reference
Tan Y, Zhang F, Fan X, Lu S, Liu Y, Wu Z, Huang Z, Wu C, Cheng G, Li B, Huang J, Stalin A, Zhou W, Wu J. Exploring the effect of Yinzhihuang granules on alcoholic liver disease based on pharmacodynamics, network pharmacology and molecular docking. Chin Med. 2023;18:52. https://doi.org/10.1186/s13020-023-00759-z.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s13020-023-00759-z.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Tan, Y., Zhang, F., Fan, X. et al. Correction: Exploring the effect of Yinzhihuang granules on alcoholic liver disease based on pharmacodynamics, network pharmacology and molecular docking. Chin Med 18, 83 (2023). https://doi.org/10.1186/s13020-023-00792-y
Published:
DOI: https://doi.org/10.1186/s13020-023-00792-y